📢 New in @cp-cellrepmed.bsky.social: Study findings identify EZH2-PI3K/mTORC1 signaling as a therapeutic vulnerability in phenotypically plastic #ProstateCancer and reveal Tristetraprolin as a contributor to therapy response.
Read the #OpenAccess article here: bit.ly/4z8WoQf